title: ASCO Provisional Clinical Opinion: Epidermal Growth Factor Receptor Mutation Testing in Practice.
abstract: ASCO has recently provided guidance on emerging data on EGFR testing for the purpose of selecting first-line therapy for persons with advanced NSCLC through its Provisional Clinical Opinion.
authors: Mount Sinai Medical Center, New York, NY; Hematology/Oncology of Indiana, Indianapolis, IN.
authors: Mary Beth
authors: MB
authors: Beasley
authors: Daniel T
authors: DT
authors: Milton